maprotiline has been researched along with tyrosine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| de Beurs, P; Leijnse-Ybema, HJ; Møller, SE; Petersen, HE; Stuart, MH; Tan, BK; Timmerman, L | 1 |
| Alter, M; Bauer, A; Karle, CA; Kathöfer, S; Katus, HA; Kiesecker, C; Kreuzer, J; Scholz, EP; Thomas, D; Zitron, E | 1 |
1 trial(s) available for maprotiline and tyrosine
| Article | Year |
|---|---|
Plasma tryptophan and tyrosine ratios to competing amino acids in relation to antidepressant response to citalopram and maprotiline. A preliminary study.
Topics: Adult; Aged; Amino Acids; Anthracenes; Antidepressive Agents; Citalopram; Depressive Disorder; Female; Humans; Maprotiline; Middle Aged; Propylamines; Prospective Studies; Psychiatric Status Rating Scales; Tryptophan; Tyrosine | 1986 |
2 other study(ies) available for maprotiline and tyrosine
| Article | Year |
|---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Atypical tetracyclic antidepressant maprotiline is an antagonist at cardiac hERG potassium channels.
Topics: Animals; Antidepressive Agents; Cell Line; Electrophysiology; Ether-A-Go-Go Potassium Channels; Humans; Maprotiline; Molecular Structure; Mutation; Oocytes; Patch-Clamp Techniques; Phenylalanine; Polycyclic Compounds; Potassium Channel Blockers; Tyrosine; Xenopus laevis | 2006 |